PERINDOPRIL-MEDIS perindopril arginine 5mg film-coated tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

perindopril arginine, Quantity: 5 mg

MAH:

Medis Pharma Pty Ltd

INN:

perindopril arginine

pharmaceutical_form:

Tablet, film coated

composition:

Excipient Ingredients: sodium starch glycollate type A; maltodextrin; magnesium stearate; lactose monohydrate; glycerol dibehenate; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350

administration_route:

Oral

units_in_package:

30, 10

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

The treatment of hypertension; The treatment of heart failure. In such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (The safety and efficacy of perindopril arginine has not been demonstrated for New York Heart Association Category IV patients); and Patients with established coronary artery disease (see Clinical Trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

leaflet_short:

Visual Identification: White, oval, biconvex, film-coated tablets engraved with two dots on one side and scored on both sides; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 6 Months; Container Temperature: Store below 30 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2015-08-07